Combination of 99mTc-labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the prediction of early response after carbon ion therapy in prostate cancer: a prospective study

Ping Li, Chang Liu, Shuang Wu, Lin Deng, guangyuan Zhang, Xin Cai, Silong Hu, Jingyi Cheng, Xiaoping Xu, Bin Wu, Xiaomao Guo, Yingjian Zhang, Qing Zhang, Shen FuResearch 2020 · DOI

Introduction

Carbon Ion Radiotherapy (CIRT) represents a significant advancement in oncology, offering a highly precise, high-dose radiation beam that minimizes damage to surrounding healthy tissues like the bladder and rectum. Despite its efficacy, CIRT is a resource-intensive treatment. In the context of prostate cancer—a disease characterized by slow progression—clinicians often face a "wait and see" period of months or years to determine treatment success via blood-based Prostate-Specific Antigen (PSA) levels. This delay represents a missed opportunity for early intervention in poor responders.

A recent prospective study investigated whether combining molecular imaging (PSMA-SPECT/CT) with functional MRI (DWI) could provide an "early warning system" just one week after treatment completion.

Methodology and Patient Cohort

The study enrolled 26 patients with localized prostate cancer undergoing CIRT at the Shanghai Proton and Heavy Ion Center. The research team employed a "before and after" imaging protocol, scanning patients prior to treatment and exactly one week following their final radiation session.

Two distinct imaging modalities were utilized to capture the biological response:

  1. $^{99m}$Tc-labeled PSMA-SPECT/CT: This molecular technique targets the Prostate-Specific Membrane Antigen (PSMA), which is overexpressed in cancerous prostate cells. The primary metric was the Tumor-to-Background Ratio (TBR).
  2. Diffusion-Weighted MRI (DWI): This functional MRI technique measures the random motion of water molecules. As radiation kills cancer cells and tissue density decreases, water movement becomes less restricted, measured by the Mean Apparent Diffusion Coefficient (ADC$_{mean}$).

The researchers then calculated the percentage change (Δ) in these values and correlated them with clinical outcomes, specifically monitoring if PSA levels dropped to ≤ 0.1 ng/mL six months post-therapy.

Table 1: Baseline characteristics and clinical profiles of the 26 patients enrolled in the study.

The patient cohort (Table 1) included a median age of 66.5 years, with a distribution across intermediate, high, and very high-risk categories. This diversity ensures the findings are applicable across various clinical presentations of localized prostate cancer.

Key Insights: Molecular vs. Structural Changes

The study's findings underscore that biological changes—specifically protein expression and water diffusivity—occur much more rapidly than structural changes like tumor shrinkage. A significant discovery was the negative correlation (p = 0.002) between the change in PSMA uptake (ΔTBR) and the change in water diffusion (ΔADC). As the tumor ceases protein production, its cellular structure breaks down, allowing freer water flow. These two independent biological signals provide a robust confirmation of cell death.

Interestingly, ΔTBR emerged as a slightly more powerful individual predictor than ΔADC. This suggests that the reduction in PSMA expression may be one of the earliest detectable signs of successful radiation-induced damage.

Results and Predictive Accuracy

The combination of both imaging techniques yielded the most impressive results:

  • Predictive Power: The combined model (TBR + ADC) achieved an Area Under the Curve (AUC) of 0.895, outperforming either method used in isolation.
  • Clinical Sensitivity and Specificity: The dual-imaging approach demonstrated 91.4% sensitivity and 95.2% specificity in distinguishing good responders from poor responders.
  • Quantitative Shifts: Post-CIRT, the mean TBR decreased significantly (from ~15.2 to ~5.5), while the ADC increased (from 0.771 × 10⁻³ to 1.172 × 10⁻³ mm²/s), confirming immediate biological impact.

Conclusion and Future Directions

While these preliminary results are promising, the authors note that larger cohorts are necessary to validate these thresholds before they can be integrated into standard clinical practice. Additionally, while the 38.3-month median follow-up is substantial, longer-term data will be essential to confirm if these one-week post-treatment scans can accurately predict 10-year survival.

Nevertheless, this study provides a compelling case for "multi-parametric" imaging in personalized oncology. By identifying poor responders early, clinicians could potentially intervene with dose escalations or adjuvant therapies years before traditional markers would signal a problem, ultimately improving outcomes for patients with localized prostate cancer.

Summary updated

Abstract

Abstract Background The purpose of this study was to assess the potential of 99mTc-labeled PSMA-SPECT/CT and Diffusion-Weighted Image (DWI) for predicting treatment response after carbon ion radiotherapy (CIRT) in prostate cancer. Methods We prospectively registered 26 patients with localized prostate cancer treated with CIRT. All patients underwent 99m Tc-labeled PSMA-SPECT/CT and multiparametric MRI before and after CIRT. The tumor/background ratio (TBR) and mean apparent diffusion coefficient (ADC mean ) were measured on the tumor and the percentage changes between 2 time points (ΔTBR and ΔADC mean ) were calculated. Patients were divided into two groups: good response and poor response according to clinical follow-up. Results The median follow up time was 38.3months. The TBR was significantly decreased ( p =0.001), while the ADC mean was significantly increased compared with the pretreatment value ( p <0.001). The ΔTBR and ΔADC mean were negatively correlated with each other ( p = 0.002). On ROC curve analysis for predicting treatment response, the area under the ROC curve (AUC) of ΔTBR (0.867) for predicting good response was higher than that of ΔADC mean (0.819). The AUC of combined with ΔTBR and ΔADC mean (0.895) was higher than that of either ΔADC mean or ΔTBR alone. The combined use of ΔTBR and ΔADC mean showed 91.4% sensitivity and 95.2% specificity. Conclusions Our preliminary data indicate that the changes of TBR and ADC mean maybe an early bio-marker for predicting prognosis after CIRT in localized prostate cancer patients. In addition, the ΔTBR was a more powerful prognostic factor than ΔADC mean in prostate cancer treated with CIRT.
BibTeX
@inproceedings{li2020combination,
  author = {Ping Li and Chang Liu and Shuang Wu and Lin Deng and guangyuan Zhang and Xin Cai and Silong Hu and Jingyi Cheng and Xiaoping Xu and Bin Wu and Xiaomao Guo and Yingjian Zhang and Qing Zhang and Shen Fu},
  title = {{Combination of 99mTc-labeled PSMA-SPECT/CT and Diffusion-Weighted MRI in the prediction of early response after carbon ion therapy in prostate cancer: a prospective study}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-16861/v1},
}
Figure